# Top 50 Medical Device Startup Investors in Asia in June 2026 ## Cowin Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 13 - Stages: Series A, Series B, Seed - Focus: Manufacturing, Health Care, Biotechnology Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market. ## Qiming Venture Partners - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 13 - Stages: Series B, Series A, Series C - Focus: Health Care, Biotechnology, Medical Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status. ## HSG - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 12 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Software We help founders build enduring companies. ## BioVenture - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 11 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation. ## Shunwei Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 11 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Software, Internet Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices. ## CD Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 10 - Stages: Series A, Series B, Seed - Focus: Health Care, Biotechnology, Medical Device CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors. ## Lilly Asia Ventures - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 10 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. ## UntroD Capital - Type: VC Fund - Location: Sumida, Tokyo, Japan - Relevant deals: 9 - Stages: Seed, Series A - Focus: Manufacturing, Biotechnology, Medical UntroD Capital is an R&D-based innovative technology that specializes in social implementation. ## BioTrack Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 9 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Health Care, Medical BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones. ## BIOCHING CAPITAL - Type: VC Fund - Location: Longgang, Guangdong, China - Relevant deals: 9 - Stages: Angel, Series A, Seed - Focus: Medical Device, Medical, Biotechnology BIOCHING CAPITAL is an investment management firm. ## Haibang Capital - Type: VC Fund - Location: Hangzhou, Zhejiang, China - Relevant deals: 8 - Stages: Series A, Angel, Series B - Focus: Health Care, Biotechnology, Manufacturing Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits. ## IDG Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 8 - Stages: Series A, Series B, Series C - Focus: Software, Internet, E-Commerce IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support. ## Addor Capital - Type: VC Fund - Location: Nanjing, Jiangsu, China - Relevant deals: 7 - Stages: Series A, Series B - Focus: Manufacturing, Semiconductor, Electronics Addor Capital offers investment services by financing early stage ventures and holding securities of other companies. ## Taiyu Investment - Type: VC Fund - Relevant deals: 7 - Stages: Seed, Series A, Angel - Focus: Medical, Health Care, Biotechnology Taiyu Investment is an investment firm. ## Prox Ventures - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 7 - Stages: Seed, Series A - Focus: Medical, Biotechnology, Health Care Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health. ## Jan Hammer - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 7 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Medical Device Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University. ## Dalton Venture - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 7 - Stages: Seed, Series A, Series B - Focus: Health Care, Medical, Biotechnology Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health. ## Med-Fine Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 7 - Stages: Series A, Seed, Series B - Focus: Medical, Health Care, Biotechnology Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen. ## Legend Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 7 - Stages: Series B, Series A, Series C - Focus: Health Care, Medical, Biotechnology Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry. ## EFung Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 7 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Medical Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion. ## Nippon Venture Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 6 - Stages: Series A, Series B - Focus: Software, Health Care, Medical Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises. ## Matrix Partners China - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 6 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Software Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages. ## Marathon Venture Partners - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 6 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry. ## CDH Investments - Type: VC Fund - Location: Kowloon City, Kowloon, Hong Kong - Relevant deals: 6 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Health Care, Biotechnology CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China. ## Oriza Seed Capital (Oriza Yuandian) - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 6 - Stages: Series A, Seed, Angel - Focus: Manufacturing, Health Care, Biotechnology Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation. ## Share Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 6 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization. ## Sunland Fund - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 5 - Stages: Series B, Series A, Seed - Focus: Medical, Health Care, Medical Device Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp.. ## JAFCO - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 5 - Stages: Series A, Series B - Focus: Information Technology, Software, Artificial Intelligence Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing. ## Fast Track Initiative, Inc. - Type: VC Fund - Location: Hongo, Tokyo, Japan - Relevant deals: 5 - Stages: Series A, Seed, Series B - Focus: Health Care, Biotechnology, Medical Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services. ## Goldport Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 5 - Stages: Series A, Seed, Angel - Focus: Manufacturing, Medical, Semiconductor Goldport Capital is a Shenzhen-based asset management company. ## Mitsubishi UFJ Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 5 - Stages: Series A, Series B - Focus: Information Technology, Software, Health Care Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments. ## Apricot Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 5 - Stages: Series A, Seed, Series B - Focus: Biotechnology, Health Care, Medical Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law. ## Fortune Venture Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 5 - Stages: Series A, Series B, Seed - Focus: Manufacturing, Software, Information Technology Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services. ## SND Ventures Group - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 5 - Stages: Series A, Series B, Seed - Focus: Manufacturing, Semiconductor, Health Care SND Ventures Group is a venture capital and private equity firm specializing in seed investments. ## SZHTI Group - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 5 - Stages: Series A, Angel - Focus: Manufacturing, Electronics, Semiconductor SZHTI Group is a company that provides asset management and financing services. ## Nissay Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 5 - Stages: Seed, Series A - Focus: Health Care, Information Technology, Medical Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment. ## Oriza Holdings - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 5 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Health Care, Biotechnology Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007. ## UTEC - The University of Tokyo Edge Capital Partners - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 4 - Stages: Seed, Series A - Focus: Health Care, Biotechnology, Medical UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo. ## UTokyo Innovation Platform - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 4 - Stages: Series A, Series B - Focus: Biotechnology, Medical, Manufacturing The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures. ## Mizuho Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 4 - Stages: Series A, Series B - Focus: Information Technology, Software, Internet Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively. ## Green Pine Capital Partners - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 4 - Stages: Series A, Series B, Angel - Focus: Biotechnology, Software, Manufacturing Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China. ## Huagai Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 4 - Stages: Series A, Series B, Angel - Focus: Health Care, Biotechnology, Medical Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture. ## ASBV - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 4 - Stages: Seed, Series A, Angel - Focus: Health Care, Medical, Biotechnology ASBV focuses on early and mid-term venture capital investments. ## Keio Innovation Initiative - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 4 - Stages: Series A, Seed - Focus: Health Care, Medical, Biotechnology Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries. ## Volcanics Venture - Type: VC Fund - Location: Changning, Shanghai, China - Relevant deals: 4 - Stages: Series A, Series B - Focus: Health Care, Artificial Intelligence, Biotechnology Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners. ## Frees Fund - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 4 - Stages: Series A, Seed, Angel - Focus: Artificial Intelligence, Health Care, Biotechnology By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology. ## HY Capital - Type: VC Fund - Location: Changning, Shanghai, China - Relevant deals: 4 - Stages: Series A, Seed, Series B - Focus: Health Care, Medical, Medical Device HY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments. ## Seeds Capital - Type: VC Fund - Location: Singapore, Central Region, Singapore - Relevant deals: 4 - Stages: Seed, Series A, Series B - Focus: Software, Biotechnology, Health Care Catalysing smart monies into Singapore-based, early-stage technology startups. ## Highlight Capital - Type: VC Fund - Location: Nanjin, Jiangsu, China - Relevant deals: 4 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect. ## Insight Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 4 - Stages: Series A, Series B, Series C - Focus: Health Care, Medical, Biotechnology Insight Capital is a venture capital firm focused on early-stage investment.